Table 2.
SNP | Genotype | Patient group (n = 1086) | Control group (n = 1122) | P* |
---|---|---|---|---|
rs1800977 | CC | 427 (39%) | 416 (37%) | 0.217 |
CT | 541 (50%) | 518 (46%) | ||
TT | 118 (11%) | 188 (17%) | ||
C | 1395 (64%) | 1350 (60%) | ||
T | 777 (36%) | 894 (40%) | ||
rs4149313 | GG | 584 (54%) | 563 (50%) | 0.872 |
GA | 455 (42%) | 462 (41%) | ||
AA | 47 (4%) | 97 (9%) | ||
G | 1623 (75%) | 1588 (71%) | ||
A | 549 (25%) | 656 (29%) | ||
rs1128503 | TT | 536 (50%) | 572 (51%) | 0.144 |
TC | 449 (41%) | 444 (40%) | ||
CC | 101 (9%) | 106 (9%) | ||
T | 1521 (70%) | 1588 (71%) | ||
C | 651 (30%) | 656 (29%) |
SNP, single nucleotide polymorphism.
*P for Hardy–Weinberg equilibrium test in the control group.